Unknown NA INTERVENTIONAL 2-arm NCT05478356

The Effects of Low-dose Atropine and Orthokeratology in Pediatric Myopia Control (AVO)

Sponsor: Evidence Based Cataract Study Group

Conditions Myopia

Interventions low-dose atropine eye drops orthokeratology

Updated 4 times since 2022 Last updated: Jul 26, 2022 Started: Aug 1, 2022 Primary completion: Aug 31, 2023 Completion: Aug 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05478356, this NA trial focuses on Myopia and remains ongoing. Sponsored by Evidence Based Cataract Study Group, it has been updated 4 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Aug 2024 — Sep 2024 [monthly]

Unknown NA

Status: Recruiting → Unknown
Jul 2024 — Aug 2024 [monthly]

Recruiting NA
Sep 2022 — Jul 2024 [monthly]

Recruiting NA

First recorded

Aug 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Evidence Based Cataract Study Group

Data source: Evidence Based Cataract Study Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China
• Shanghai, China